Scholars@Duke publication: Pharmacokinetics of 14C-Labeled Zalunfiban (RUC-4) Suggests That No Dose Adjustment Is Necessary for Impaired Renal Function

Pharmacokinetics of 14C-Labeled Zalunfiban (RUC-4) Suggests That No Dose Adjustment Is Necessary for Impaired Renal Function

Publication , Conference

MacArthur, R; Rikken, S; Coller, B; Gibson, CM; Granger, C; Montalescot, G; Ten Berg, J; van't Hof, A

Published in: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2024

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

1558-3597

0735-1097

2024

B81 / B81

APA

Chicago

ICMJE

MLA

NLM

MacArthur, R., Rikken, S., Coller, B., Gibson, C. M., Granger, C., Montalescot, G., … van’t Hof, A. (2024). Pharmacokinetics of 14C-Labeled Zalunfiban (RUC-4) Suggests That No Dose Adjustment Is Necessary for Impaired Renal Function. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 84, pp. B81–B81).

MacArthur, Robert, Sem Rikken, Barry Coller, C Michael Gibson, Christopher Granger, Gilles Montalescot, Jurrien Ten Berg, and Arnoud van’t Hof. “Pharmacokinetics of 14C-Labeled Zalunfiban (RUC-4) Suggests That No Dose Adjustment Is Necessary for Impaired Renal Function.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 84:B81–B81, 2024.

MacArthur R, Rikken S, Coller B, Gibson CM, Granger C, Montalescot G, et al. Pharmacokinetics of 14C-Labeled Zalunfiban (RUC-4) Suggests That No Dose Adjustment Is Necessary for Impaired Renal Function. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2024. p. B81–B81.

MacArthur R, Rikken S, Coller B, Gibson CM, Granger C, Montalescot G, Ten Berg J, van’t Hof A. Pharmacokinetics of 14C-Labeled Zalunfiban (RUC-4) Suggests That No Dose Adjustment Is Necessary for Impaired Renal Function. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2024. p. B81–B81.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

1558-3597

0735-1097

2024

B81 / B81